AstraZeneca chief quits as profits slump by 40 per cent

Drugs giant looking for a new strategy after CEO Brennan quits hours before shareholder meeting

The chief executive of AstraZeneca, David Brennan, shocked the markets by announcing his resignation yesterday in an apparent boardroom coup just hours before the pharmaceuticals giant's shareholder meeting kicked off.

Mr Brennan's departure appeared to be a victory for investors who had called for change at the top of the FTSE 100 drugs giant, which is suffering from dramatically falling revenues as key drugs face generic competition, as well as a weak pipeline of new drugs.

Yesterday the drug maker added a profits warning to its other woes. Its first-quarter pre-tax profit plunged 40 per cent to $2.05bn (£1.26bn) – well below City expectations – but it admitted the full-year profit would also be worse.

One investor at the AGM at a London hotel shouted "shame on you" to Astra's board for "sniping" at Mr Brennan in newspaper stories, complaining about his lack of leadership as revenues began drying up. Another said the drug maker's performance targets should be "more demanding" as "too much money" was thrown at executives.

Mr Brennan, an American who started his career selling blood-pressure pills to doctors in Jersey City, pocketed a £9.1m salary last year.

Britain's second-biggest drug maker said Mr Brennan had told the board of his departure only yesterday. Instead of serving out his 12-month notice, he will retire on 1 June and be replaced, temporarily, by the finance director, Simon Lowth.

In addition, Leif Johansson, the former Volvo boss who is to succeed Louis Schweitzer as chairman, will take over three months earlier than planned, also on 1 June.

Although Mr Johansson only joined the board this week, some people close to Astra said he was closely involved in the decision that Mr Brennan should go sooner rather than later. "Having someone in a lame-duck position wasn't consider helpful," a source close to the board told Reuters.

Astra said Mr Brennan's departure terms had not yet been decided but he could pocket £1m – a year's basic salary – as part of a pay-off package.

Mr Brennan said yesterday: "I have decided that now is the right time to step down and allow a new leader to take the reins."

The 58-year-old replaced Sir Tom McKillop in AstraZeneca's top job in 2006. The company was already well aware of the creeping patent expiries that would wipe billions off its annual revenues. Mr Brennan reacted by slashing jobs – it is set to get rid of 12 per cent of its 60,000 workforce by 2014 – and going on a shopping spree.

But the M&A strategy, including the troublesome $15.6bn deal to buy MedImmune in 2007, failed as the acquired firms' new drugs faltered at trials. In recent months three drugs earmarked for their potential have all failed and then been dumped after drugs trials.

Meanwhile, the patent problems remain. Seroquel, Astra's antipsychotic drug that accounted for sales of $5.3bn last year, came out of patent in the key US market last month. The cholesterol-buster Crestor, AstraZeneca's best-selling drug, faces generic rivals from 2016.

Shares in AstraZeneca fell more than 6 per cent or 174.5p to 2,666.5p.

Start your day with The Independent, sign up for daily news emails
ebooks
ebooksA celebration of British elections
  • Get to the point
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Ashdown Group: Editor-in-chief - Financial Services - City, London

£60000 - £70000 per annum + benefits : Ashdown Group: A highly successful, glo...

Ashdown Group: Junior Application Support Analyst - Fluent German Speaker

£25000 - £30000 per annum + benefits: Ashdown Group: A global leader operating...

Guru Careers: Management Accountant

£27 - 35k + Bonus + Benefits: Guru Careers: A Management Accountant is needed ...

Guru Careers: Project Manager / Business Analyst

£40-50k + Benefits.: Guru Careers: A Project Manager / Business Analyst is nee...

Day In a Page

General Election 2015: ‘We will not sit down with Nicola Sturgeon’, says Ed Balls

'We will not sit down with Nicola Sturgeon'

In an exclusive interview, Ed Balls says he won't negotiate his first Budget with SNP MPs - even if Labour need their votes to secure its passage
VE Day 70th anniversary: How ordinary Britons celebrated the end of war in Europe

How ordinary Britons celebrated VE Day

Our perception of VE Day usually involves crowds of giddy Britons casting off the shackles of war with gay abandon. The truth was more nuanced
They came in with William Caxton's printing press, but typefaces still matter in the digital age

Typefaces still matter in the digital age

A new typeface once took years to create, now thousands are available at the click of a drop-down menu. So why do most of us still rely on the old classics, asks Meg Carter?
Discovery of 'missing link' between the two main life-forms on Earth could explain evolution of animals, say scientists

'Missing link' between Earth's two life-forms found

New microbial species tells us something about our dark past, say scientists
Ronald McDonald the muse? Why Banksy, Ron English and Keith Coventry are lovin' Maccy D's

Ronald McDonald the muse

A new wave of artists is taking inspiration from the fast food chain
13 best picnic blankets

13 best picnic blankets

Dine al fresco without the grass stains and damp bottoms with something from our pick of picnic rugs
General Election 2015: Ed Miliband's unlikely journey from hapless geek to heart-throb

Miliband's unlikely journey from hapless geek to heart-throb

He was meant to be Labour's biggest handicap - but has become almost an asset
General Election 2015: A guide to the smaller parties, from the the National Health Action Party to the Church of the Militant Elvis Party

On the margins

From Militant Elvis to Women's Equality: a guide to the underdogs standing in the election
Amr Darrag: Ex-Muslim Brotherhood minister in exile still believes Egypt's military regime can be replaced with 'moderate' Islamic rule

'This is the battle of young Egypt for the future of our country'

Ex-Muslim Brotherhood minister Amr Darrag still believes the opposition can rid Egypt of its military regime and replace it with 'moderate' Islamic rule, he tells Robert Fisk
Why patients must rely less on doctors: Improving our own health is the 'blockbuster drug of the century'

Why patients must rely less on doctors

Improving our own health is the 'blockbuster drug of the century'
Sarah Lucas is the perfect artist to represent Britain at the Venice Biennale

Flesh in Venice

Sarah Lucas has filled the British pavilion at the Venice Biennale with slinky cats and casts of her female friends' private parts. It makes you proud to be a woman, says Karen Wright
11 best anti-ageing day creams

11 best anti-ageing day creams

Slow down the ageing process with one of these high-performance, hardworking anti-agers
Juventus 2 Real Madrid 1: Five things we learnt, including Iker Casillas is past it and Carlos Tevez remains effective

Juventus vs Real Madrid

Five things we learnt from the Italian's Champions League first leg win over the Spanish giants
Ashes 2015: Test series looks a lost cause for England... whoever takes over as ECB director of cricket

Ashes series looks a lost cause for England...

Whoever takes over as ECB director of cricket, says Stephen Brenkley
Fishing for votes with Nigel Farage: The Ukip leader shows how he can work an audience as he casts his line to the disaffected of Grimsby

Fishing is on Nigel Farage's mind

Ukip leader casts a line to the disaffected